98 related articles for article (PubMed ID: 20977411)
21. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.
Srivareerat M; Tran TT; Salim S; Aleisa AM; Alkadhi KA
Neurobiol Aging; 2011 May; 32(5):834-44. PubMed ID: 19464074
[TBL] [Abstract][Full Text] [Related]
22. Memory loss caused by beta-amyloid protein is rescued by a beta(3)-adrenoceptor agonist.
Gibbs ME; Maksel D; Gibbs Z; Hou X; Summers RJ; Small DH
Neurobiol Aging; 2010 Apr; 31(4):614-24. PubMed ID: 18632189
[TBL] [Abstract][Full Text] [Related]
23. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
Izco M; Martínez P; Corrales A; Fandos N; García S; Insua D; Montañes M; Pérez-Grijalba V; Rueda N; Vidal V; Martínez-Cué C; Pesini P; Sarasa M
Neuroscience; 2014 Mar; 263():269-79. PubMed ID: 24447596
[TBL] [Abstract][Full Text] [Related]
24. Safflower yellow reduces lipid peroxidation, neuropathology, tau phosphorylation and ameliorates amyloid β-induced impairment of learning and memory in rats.
Ma Q; Ruan YY; Xu H; Shi XM; Wang ZX; Hu YL
Biomed Pharmacother; 2015 Dec; 76():153-64. PubMed ID: 26653563
[TBL] [Abstract][Full Text] [Related]
25. Cognitive-enhancing and antioxidant activities of inhaled coriander volatile oil in amyloid β(1-42) rat model of Alzheimer's disease.
Cioanca O; Hritcu L; Mihasan M; Hancianu M
Physiol Behav; 2013 Aug; 120():193-202. PubMed ID: 23958472
[TBL] [Abstract][Full Text] [Related]
26. Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease.
Iijima K; Liu HP; Chiang AS; Hearn SA; Konsolaki M; Zhong Y
Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6623-8. PubMed ID: 15069204
[TBL] [Abstract][Full Text] [Related]
27. A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer's disease.
Shahpasand-Kroner H; Klafki HW; Bauer C; Schuchhardt J; Hüttenrauch M; Stazi M; Bouter C; Wirths O; Vogelgsang J; Wiltfang J
Alzheimers Res Ther; 2018 Dec; 10(1):121. PubMed ID: 30526652
[TBL] [Abstract][Full Text] [Related]
28. Satureja bachtiarica ameliorate beta-amyloid induced memory impairment, oxidative stress and cholinergic deficit in animal model of Alzheimer's disease.
Soodi M; Saeidnia S; Sharifzadeh M; Hajimehdipoor H; Dashti A; Sepand MR; Moradi S
Metab Brain Dis; 2016 Apr; 31(2):395-404. PubMed ID: 26638718
[TBL] [Abstract][Full Text] [Related]
29. Serum beta-amyloid correlates with neuropsychological impairment.
Luis CA; Abdullah L; Paris D; Quadros A; Mullan M; Mouzon B; Ait-Ghezala G; Crawford F; Mullan M
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2009 Mar; 16(2):203-18. PubMed ID: 18923961
[TBL] [Abstract][Full Text] [Related]
30. Exogenous galanin attenuates spatial memory impairment and decreases hippocampal β-amyloid levels in rat model of Alzheimer's disease.
Li L; Yu L; Kong Q
Int J Neurosci; 2013 Nov; 123(11):759-65. PubMed ID: 23687905
[TBL] [Abstract][Full Text] [Related]
31. Beta-sheet breaker peptide prevents Abeta-induced spatial memory impairments with partial reduction of amyloid deposits.
Chacón MA; Barría MI; Soto C; Inestrosa NC
Mol Psychiatry; 2004 Oct; 9(10):953-61. PubMed ID: 15098004
[TBL] [Abstract][Full Text] [Related]
32. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
[TBL] [Abstract][Full Text] [Related]
33. Association of cardiovascular factors and Alzheimer's disease plasma amyloid-beta protein in subjective memory complainers.
Bates KA; Sohrabi HR; Rodrigues M; Beilby J; Dhaliwal SS; Taddei K; Criddle A; Wraith M; Howard M; Martins G; Paton A; Mehta P; Foster JK; Martins IJ; Lautenschlager NT; Mastaglia FL; Laws SM; Gandy SE; Martins RN
J Alzheimers Dis; 2009; 17(2):305-18. PubMed ID: 19363264
[TBL] [Abstract][Full Text] [Related]
34. Nobiletin restoring beta-amyloid-impaired CREB phosphorylation rescues memory deterioration in Alzheimer's disease model rats.
Matsuzaki K; Yamakuni T; Hashimoto M; Haque AM; Shido O; Mimaki Y; Sashida Y; Ohizumi Y
Neurosci Lett; 2006 Jun; 400(3):230-4. PubMed ID: 16581185
[TBL] [Abstract][Full Text] [Related]
35. [Gly14]-Humanin Protects Against Amyloid β Peptide-Induced Impairment of Spatial Learning and Memory in Rats.
Yuan L; Liu XJ; Han WN; Li QS; Wang ZJ; Wu MN; Yang W; Qi JS
Neurosci Bull; 2016 Aug; 32(4):374-82. PubMed ID: 27306655
[TBL] [Abstract][Full Text] [Related]
36. Hippocampal nitric oxide upregulation precedes memory loss and A beta 1-40 accumulation after chronic brain hypoperfusion in rats.
de la Torre JC; Pappas BA; Prevot V; Emmerling MR; Mantione K; Fortin T; Watson MD; Stefano GB
Neurol Res; 2003 Sep; 25(6):635-41. PubMed ID: 14503018
[TBL] [Abstract][Full Text] [Related]
37. Neuroprotective effects of a Rhodiola crenulata extract on amyloid-β peptides (Aβ
Zhang X; Wang X; Hu X; Chu X; Li X; Han F
Phytomedicine; 2019 Apr; 57():331-338. PubMed ID: 30807987
[TBL] [Abstract][Full Text] [Related]
38. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
Chavant F; Deguil J; Pain S; Ingrand I; Milin S; Fauconneau B; Pérault-Pochat MC; Lafay-Chebassier C
J Pharmacol Exp Ther; 2010 Feb; 332(2):505-14. PubMed ID: 19889791
[TBL] [Abstract][Full Text] [Related]
39. Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer's disease.
Klakotskaia D; Agca C; Richardson RA; Stopa EG; Schachtman TR; Agca Y
PLoS One; 2018; 13(4):e0195469. PubMed ID: 29641600
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological and Toxicological Properties of the Potent Oral
Wagner SL; Rynearson KD; Duddy SK; Zhang C; Nguyen PD; Becker A; Vo U; Masliah D; Monte L; Klee JB; Echmalian CM; Xia W; Quinti L; Johnson G; Lin JH; Kim DY; Mobley WC; Rissman RA; Tanzi RE
J Pharmacol Exp Ther; 2017 Jul; 362(1):31-44. PubMed ID: 28416568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]